FEMA551413
n-Myc Recombinant Rabbit Monoclonal Antibody (5W7L9), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FEMA551413-Each-of-1 | In Stock | ₹ 36,619.68 |
FEMA551413 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,619.68
GST (18%): ₹ 6,591.542
Total Price: ₹ 43,211.222
Antigen
n-Myc
Classification
Recombinant Monoclonal
Concentration
0.12 mg/mL
Formulation
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.
P04198
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
4613
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Isotype
IgG
Applications
Western Blot
Clone
5W7L9
Conjugate
Unconjugated
Gene
MYCN
Gene Alias
Avian myelocytomatosis viral (v-myc) related oncogene neuroblastoma derived (Nmyc), Avian myelocytomatosis viral (v-myc) related oncogene, neuroblastoma derived (Nmyc), BHLHE37, Class E basic helix-loop-helix protein 37, c-nmyc, fb57a02, MODED, Mycn, mycn protein, MYCN proto-oncogene, bHLH transcription factor, neuroblastoma MYC oncogene, neuroblastoma myc-related oncogene 1, neuroblastoma-derived v-myc avian myelocytomatosis viral related oncogene, Nmuc1, NMYC, N-myc, N-myc protein, N-myc proto-oncogene protein, Nmyc1, Nmyc-1, N-myc-like protein, ODED, oncogene NMYC, oncogene pp65/67, pp65/67, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian), wu:fb57a02, zgc:85706
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human N-Myc/MYCN (NP_005369.2).
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Format
Liquid
Description
- Immunogen sequence: MPSCSTSTMP GMICKNPDLE FDSLQPCFYP DEDDFYFGGP DSTPPGEDIW KKFELLPTPP LSPSRGFAEH SSEPPSWVTE MLLENELWGS PAEEDAFGLG n-Myc Recombinant Monoclonal antibody specifically detects n-Myc in Human samples
- It is validated for Western Blot
Compare Similar Items
Show Difference
Antigen: n-Myc
Classification: Recombinant Monoclonal
Concentration: 0.12 mg/mL
Formulation: PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.: P04198
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 4613
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Isotype: IgG
Applications: Western Blot
Clone: 5W7L9
Conjugate: Unconjugated
Gene: MYCN
Gene Alias: Avian myelocytomatosis viral (v-myc) related oncogene neuroblastoma derived (Nmyc), Avian myelocytomatosis viral (v-myc) related oncogene, neuroblastoma derived (Nmyc), BHLHE37, Class E basic helix-loop-helix protein 37, c-nmyc, fb57a02, MODED, Mycn, mycn protein, MYCN proto-oncogene, bHLH transcription factor, neuroblastoma MYC oncogene, neuroblastoma myc-related oncogene 1, neuroblastoma-derived v-myc avian myelocytomatosis viral related oncogene, Nmuc1, NMYC, N-myc, N-myc protein, N-myc proto-oncogene protein, Nmyc1, Nmyc-1, N-myc-like protein, ODED, oncogene NMYC, oncogene pp65/67, pp65/67, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian), wu:fb57a02, zgc:85706
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human N-Myc/MYCN (NP_005369.2).
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Format: Liquid
Antigen:
n-Myc
Classification:
Recombinant Monoclonal
Concentration:
0.12 mg/mL
Formulation:
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.:
P04198
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
4613
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Isotype:
IgG
Applications:
Western Blot
Clone:
5W7L9
Conjugate:
Unconjugated
Gene:
MYCN
Gene Alias:
Avian myelocytomatosis viral (v-myc) related oncogene neuroblastoma derived (Nmyc), Avian myelocytomatosis viral (v-myc) related oncogene, neuroblastoma derived (Nmyc), BHLHE37, Class E basic helix-loop-helix protein 37, c-nmyc, fb57a02, MODED, Mycn, mycn protein, MYCN proto-oncogene, bHLH transcription factor, neuroblastoma MYC oncogene, neuroblastoma myc-related oncogene 1, neuroblastoma-derived v-myc avian myelocytomatosis viral related oncogene, Nmuc1, NMYC, N-myc, N-myc protein, N-myc proto-oncogene protein, Nmyc1, Nmyc-1, N-myc-like protein, ODED, oncogene NMYC, oncogene pp65/67, pp65/67, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived, v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian), wu:fb57a02, zgc:85706
Immunogen:
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human N-Myc/MYCN (NP_005369.2).
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Format:
Liquid
Antigen: Neuropilin 1
Classification: Recombinant Monoclonal
Concentration: 0.073 mg/mL
Formulation: PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.: O14786
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 8829
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Isotype: IgG
Applications: Western Blot
Clone: 9X7L4
Conjugate: Unconjugated
Gene: NRP1
Gene Alias: A5 protein, BDCA4, C530029I03, CD304, Neuropilin, neuropilin 1, Neuropilin1, neuropilin-1, Neuropilin-1 precursor (A5 protein), NP1, NP-1, Npn1, NPN-1, NRP, NRP 1, Nrp1, sNRP 1, sNRP1, soluble NRP 1, soluble NRP1, transmembrane receptor, vascular endothelial cell growth factor 165 receptor, VEGF165R
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 22-644 of human Neuropilin-1 (NRP1) (NP_003864.5).
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Format: Liquid
Antigen:
Neuropilin 1
Classification:
Recombinant Monoclonal
Concentration:
0.073 mg/mL
Formulation:
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.:
O14786
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
8829
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Isotype:
IgG
Applications:
Western Blot
Clone:
9X7L4
Conjugate:
Unconjugated
Gene:
NRP1
Gene Alias:
A5 protein, BDCA4, C530029I03, CD304, Neuropilin, neuropilin 1, Neuropilin1, neuropilin-1, Neuropilin-1 precursor (A5 protein), NP1, NP-1, Npn1, NPN-1, NRP, NRP 1, Nrp1, sNRP 1, sNRP1, soluble NRP 1, soluble NRP1, transmembrane receptor, vascular endothelial cell growth factor 165 receptor, VEGF165R
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 22-644 of human Neuropilin-1 (NRP1) (NP_003864.5).
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Format:
Liquid
Antigen: TGF beta-1
Classification: Recombinant Monoclonal
Concentration: 0.6 mg/mL
Formulation: PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.: P01137, P17246
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 59086, 7040
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Isotype: IgG
Applications: Immunocytochemistry, Western Blot
Clone: 4A4P3
Conjugate: Unconjugated
Gene: Tgfb1
Gene Alias: CED, cytokine, DPD1, LAP, Latency-associated peptide, prepro-transforming growth factor beta-1, regulatory protein, TGF b, TGF b 1, TGF beta, tgf beta 1, tgf beta1, TGF beta-1, TGF beta-1 protein, TGF β, TGF β 1, TGF β1, Tgfb, TGFB1, TGF-B1, Tgfb-1, TGFbeta, TGF-beta 1, TGF-beta 1 protein, TGFbeta1, TGF-beta1, TGF-beta-1, TGFβ1, Transforming growth factor, transforming growth factor b1, transforming growth factor beta, transforming growth factor beta 1, transforming growth factor beta-1, Transforming growth factor beta-1 proprotein, transforming growth factor beta-1 proprotein, transforming growth factor beta-1, transforming growth factor β1, transforming growth factor, beta 1, transforming growth factor, beta 1 (Camurati-Engelmann disease), transforming growth factor, beta-1, transforming growth factor-beta 1, transforming growth factor-beta I, transforming growth factor-beta-1, transforming growth factor-beta-1 precursor, unnamed protein product
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 30-390 of human TGF beta 1 (NP_000651.3).
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Rat
Format: Liquid
Antigen:
TGF beta-1
Classification:
Recombinant Monoclonal
Concentration:
0.6 mg/mL
Formulation:
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.:
P01137, P17246
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
59086, 7040
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Isotype:
IgG
Applications:
Immunocytochemistry, Western Blot
Clone:
4A4P3
Conjugate:
Unconjugated
Gene:
Tgfb1
Gene Alias:
CED, cytokine, DPD1, LAP, Latency-associated peptide, prepro-transforming growth factor beta-1, regulatory protein, TGF b, TGF b 1, TGF beta, tgf beta 1, tgf beta1, TGF beta-1, TGF beta-1 protein, TGF β, TGF β 1, TGF β1, Tgfb, TGFB1, TGF-B1, Tgfb-1, TGFbeta, TGF-beta 1, TGF-beta 1 protein, TGFbeta1, TGF-beta1, TGF-beta-1, TGFβ1, Transforming growth factor, transforming growth factor b1, transforming growth factor beta, transforming growth factor beta 1, transforming growth factor beta-1, Transforming growth factor beta-1 proprotein, transforming growth factor beta-1 proprotein, transforming growth factor beta-1, transforming growth factor β1, transforming growth factor, beta 1, transforming growth factor, beta 1 (Camurati-Engelmann disease), transforming growth factor, beta-1, transforming growth factor-beta 1, transforming growth factor-beta I, transforming growth factor-beta-1, transforming growth factor-beta-1 precursor, unnamed protein product
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 30-390 of human TGF beta 1 (NP_000651.3).
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Rat
Format:
Liquid
Antigen: MMP13
Classification: Recombinant Monoclonal
Concentration: 1 mg/mL
Formulation: PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.: P45452
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 4322
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Isotype: IgG
Applications: Immunocytochemistry
Clone: 1W9V10
Conjugate: Unconjugated
Gene: MMP13
Gene Alias: cb1034, Clg, CLG3, Collagenase, collagenase 3, collagenase 3a, matrix metalloproteinase 13a, collagenase-1, Collagenase3, Collagenase-3, collagenase-3 precursor, interstitial collagenase, MANDP1, matrix metallo protease, matrix metallopeptidase 13, matrix metallopeptidase 13 (collagenase 3), matrix metallopeptidase 13a, matrix metallopeptidase 13a (collagenase 3), matrix metalloproteinase 13, matrix metalloproteinase 13 (collagenase 3), matrix metalloproteinase-13, matrix metalloproteinase-13, MMP-13, interstitial protein, MMP, Mmp1, MMP13, MMP-13, mmp13 protein, mmp13a, MMPLg, MMPLh, MMPs, Procollagenase 3, UMRCASE, ZFMMP13
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 104-272 of human MMP13 (NP_002418.1).
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Format: Liquid
Antigen:
MMP13
Classification:
Recombinant Monoclonal
Concentration:
1 mg/mL
Formulation:
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.:
P45452
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
4322
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Isotype:
IgG
Applications:
Immunocytochemistry
Clone:
1W9V10
Conjugate:
Unconjugated
Gene:
MMP13
Gene Alias:
cb1034, Clg, CLG3, Collagenase, collagenase 3, collagenase 3a, matrix metalloproteinase 13a, collagenase-1, Collagenase3, Collagenase-3, collagenase-3 precursor, interstitial collagenase, MANDP1, matrix metallo protease, matrix metallopeptidase 13, matrix metallopeptidase 13 (collagenase 3), matrix metallopeptidase 13a, matrix metallopeptidase 13a (collagenase 3), matrix metalloproteinase 13, matrix metalloproteinase 13 (collagenase 3), matrix metalloproteinase-13, matrix metalloproteinase-13, MMP-13, interstitial protein, MMP, Mmp1, MMP13, MMP-13, mmp13 protein, mmp13a, MMPLg, MMPLh, MMPs, Procollagenase 3, UMRCASE, ZFMMP13
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 104-272 of human MMP13 (NP_002418.1).
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Format:
Liquid